Mortality in Paediatric Intensive Care

NCT ID: NCT03969355

Last Updated: 2023-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-25

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mortality of paediatric patients in intensive care can be considered as on of the parameters of quality of care. Together with the advance in research and medicine there should be a trend towards mortality reduction, however actual data in Czech Republic are not well documented. The aim of this retrospective cohort trial was to evaluate the mortality of paediatric intensive care patients admitted to Department of paediatric anaesthesiology and intensive care between two periods 2008-2012 and 2013 and 2017

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mortality of paediatric patients in intensive care can be considered as on of the parameters of quality of care. Together with the advance in research and medicine there should be a trend towards mortality reduction, however actual data in Czech Republic are not well documented. The aim of this retrospective cohort trial was to evaluate the mortality of paediatric intensive care patients admitted to Department of paediatric anaesthesiology and intensive care between two periods 2008-2012 and 2013 and 2017. The patients records was retrospectively searched and the mortality was adjusted according to the primary admission diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morbidity, Multiple

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Paediatric patients 2008-2012

Paediatric patients admitted to intensive care in 2008-2012 who died during PICU stay

Mortality

Intervention Type OTHER

Patients who died during PICU stay

Paediatric patients 2013-2017

Paediatric patients admitted to intensive care in 2013-2017 who died during PICU stay

Mortality

Intervention Type OTHER

Patients who died during PICU stay

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mortality

Patients who died during PICU stay

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients admitted to intensive care in selected time period

Exclusion Criteria

* Insufficient documentation
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brno University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Petr Štourač, MD

assoc.prof.MD,Ph.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Petr Štourač, assoc.Prof.MD.Ph.D

Role: STUDY_CHAIR

University Hospital Brno

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Brno

Brno, , Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jozef Klučka, MD

Role: CONTACT

532234696 ext. 4200

Roman Stoudek, MD

Role: CONTACT

532234696 ext. 4200

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jozef Klučka, MD

Role: primary

532234696 ext. 4200

Roman Stoudek, MD

Role: backup

532234696 ext. 4200

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KDAR FN Brno 2019/4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.